PCI Pharma Services is investing to expand its flagship manufacturing center in Tredegar, Wales, which will double its highly potent tableting capacity and see an increase in general throughput to support recent and anticipated product launches. It is the latest investment at PCI’s core manufacturing site within its global network, made in direct response to customer needs and market growth.   “We are delighted to announce these most recent investments as part of both our business continuity a...